Michael Davis, PhD
Professor, University of Missouri, Former Grantee
Dr. Davis’s lab focuses on the mechanical and electrophysiological properties of lymphatic smooth muscle and endothelium and how dysfunction of those cell types contributes to lymphedema.
Lee Denson, MD
Professor, Cincinnati Children’s Hospital Medical Center, Current Grantee
Dr. Denson’s multi-center research program focuses on discovering underlying mechanisms and better therapeutic approaches in chronic inflammation, growth and mucosal healing related to adult and pediatric patients with IBD.
Gretchen Diehl, PhD
Associate Professor, Memorial Sloan Kettering Cancer Center, Former Grantee
The Gretchen Diehl lab aims to understand the cellular and molecular processes limiting inflammation against the microbiota, with a focus on CX3CR1 expressing mononuclear phagocyte, a cell lineage they believe is critical in regulating homeostasis.
Arif Ekici, PhD
Institute of Human Genetics, University Hospital Erlangen, Former Grantee
Dr. Ekici is using the newest technology for high-throughput profiling and data analysis in a broad spectrum of human genetics research.
Eran Elinav, MD, PhD
Professor, Deutsches Krebsforschungszentrum (DKFZ) Weizmann Institute of Science, Current Grantee
The ElinavLab studies the interactions between the mammalian host and its microbiome to uncover effects on health and disease. They harness experimental biology, human trials and big data analyses to devise microbiome-based personalized medicine.
Charles O. Elson, MD
Professor, University of Alabama at Birmingham, Former Grantee
Dr. Elson’s lab focuses on the regulation of mucosal immune responses, particularly the mucosal immune response to the microbiota, to define the cellular and molecular mechanisms that maintain mucosal immune homeostasis.
